Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy

BJU International

Volumn 84, Issue 1, 1999, Pages 112-117

  Okegawa, T ^a   Nutahara, K ^a   Higashihara, K ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Prognosis; Prostate cancer; Prostate specific antigen; Prostate specific membrane antigen; Reverse transcriptase polymerase chain reaction

Indexed keywords

MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032783120     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00076.x     Document Type: Article

References (26)

1. 1 Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinorna of the prostate. J Urol 1991; 145: 907-23
2. 2 Lange PH, Lighter DJ, Medini E. The effect of radiation therapy after prostateetomy in patients with evaluation of prostate specific antigen levels. J Urol 1990; 144: 927-33
3. 3 Epstein JI, Partin AW, Sauvageot J. Prediction of progression following radical prostatectomy: a mullivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996; 20: 286-92
4. 4 Stamey TA, Kabalin JN, McNeal JE. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate II. Radical prostatectomy treated patients. J Urol 1989; 141: 1076-83
5. 5 Catalona WJ, Smith DJ. Five-year tumor recurrence rates after anatomic radical prostatectomy for prostate cancer. J Urol 1994; 152: 1837-42
6. 6 Stein A, deKemion JB, Smith RB. Prostate specific antigen levels after radical prostatectomy in patients with organ conlined and locally extensive prostate cancer. J Urol 1992; 147: 942-6
7. 7 Pound CR, Partin AW, Epstein JI, Walsh PC. PSA following anatomical radical retropubic prostatectomy: patterns of recurrence and cancer control. Urol Clin N Am 1997; 24: 395-406
8. 8 Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin N Amer 1993; 20: 713-25
9. 9 Lamer J, Gay S, Grizos W, Fortier G, Malcon R. Significance of CT-scan-detected seminal vesicle enlargement in prostate cancer. A pilot study. Urology 1993; 41: 259-64
10. 10 Outer EK, Petersen RO, Siegelman ES, Gomella LG, Chernesky CE, Mitchell DG. Prostate carcinoma: assessment of diagnostic criteria of capsular penetration on endorectal coil MRI images. Radiology 1994; 193: 333-9
11. 11 Ravery V, Boccon-Gibod LA, Meulemans A, Dauge-Geffroy MC, Toubanc M, Boccon-Gibod L. Predictive value of pathological features for progression after radical prostatectomy. Eur Urol 1994; 26: 197-201
12. 12 Okegawa T, Yoshioka J, Morita R, Nutahara K, Tsukada Y, Higashihara E. Molecular staging of prostate cancer: comparison of the nested reverse transcription polymerase chain reaction assay of prostate specific antigen versus prostate specific membrane antigen as primer. Int J Urol 1998; 5: 349-56
13. 13 International Union Against Cancer. TNM Classification of Malignant Tumours. Urological tumours: prostate, 5th edn. New York: Wiley-Liss, 1997: 170-3
14. 14 Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum M ed. Urologic Pathology: The Prostate. Philadelphia: Lea & Febiger, 1977: 171-98
15. 15 Lange P, Ercole CJ, Lightner DH, Fraley EE, Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141: 873-9
16. 16 Lightner DJ, Lange P, Reddy PK, Moore L. Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 1990; 144: 921-6
17. 17 Oesterling JU, Chan DW, Epstein JI et al. Prostate specific antigen in the preoperalive and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988; 139: 766-72
18. 18 Israeli RS, Miller WH Jr, Su SL et al. Sensitive detection of nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate specific membrane antigen and prostate specific antigen based assays. Cancer Res 1994; 54: 6306-10
19. 19 Loric S, Dumas F, Eschwege P et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcriptase polymerase chain renction assay based on prostate specific membrane antigen. Clin Chem 1995; 41: 1698-704
20. 20 Katz AE, deVries GM, Olsson CA et al. Molecular staging of genitourinary malignancies. Urology 1996; 47: 948-58
21. 21 Olsson CA, de Vries GM, Raffo A et al. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy: molecular staging of prostate cancer, J Urol 1946; 155: 1557-62
22. 22 Zhang Y, Zippe CD, Lente FV, Klein E, Gupta MK. Combined nested reverse transcription PCR assay for prostate specific antigen and prostate specific membrane antigen in detecting circulating prostatic cells. Clin Cancer Res 1997; 3: 1215-20
23. 23 Hachiya T, Endo M, Nogaki J. Ishida H, Okada K. Significane of prostate specific antigen after radical prostatectomy. Int J Urol 1997; 4: 461-6
24. 24 Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropublic prostatectomy: results at 10 years. J Urol 1994; 152: 1831-5
25. 25 Takayama TK, Krieger JN, True LD, Lange PH. Recurrent prostate cancer despite undetectable prostate specific antigen. J Urol 1992; 148: 1541-2
26. 26 Ellis WJ, Vessella RL, Corey E et al. the value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer. J Urol 1998; 159: 1134-8